Common Contracts
5 similar Registration Rights Agreement contracts by Applied Therapeutics Inc., Frequency Therapeutics, Inc., Stereotaxis, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 29th, 2024 • Applied Therapeutics Inc. • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 27, 2024, by and among Applied Therapeutics, Inc., a Delaware corporation, with principal office located at 545 Fifth Avenue, Suite 1400, New York, New York 10017 (the "Company") and the undersigned buyers, (each, a "Buyer" and, collectively, the "Buyers").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 24th, 2023 • Applied Therapeutics Inc. • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of April 23, 2023, by and among Applied Therapeutics, Inc., a Delaware corporation, with principal office located at 545 Fifth Avenue, Suite 1400, New York, New York 10017 (the "Company") and the undersigned buyers, (each, a "Buyer" and, collectively, the "Buyers").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 21st, 2020 • Frequency Therapeutics, Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 12th, 2019 • Applied Therapeutics Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 7, 2019, by and among Applied Therapeutics, Inc., a Delaware corporation, with principal office located at 545 5th Avenue, Suite 1400, New York, New York 10173 (the “Company”) and the undersigned buyers, (each, an “Initial Buyer” and, collectively, the “Initial Buyers”) and any additional stockholder that becomes party to this Agreement in accordance with Section 11(n) hereto (each, an “Additional Buyer” and, collectively, the “Additional Buyers” and, together with the Initial Buyers, each a “Buyer” and together, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 8th, 2019 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 7, 2019, by and among Stereotaxis, Inc., a Delaware corporation, with principal office located at 4320 Forest Park Avenue, Suite 100, St. Louis, MO 63108 (the “Company”), and the undersigned buyers (each, a “Buyer” and, collectively, the “Buyers”).
